« Back
Home /
BMS-214662

BMS-214662

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Uterine, Ovarian & Cervical Cancer
Type	Inhibitors
Specific against	other
Amount	1 mg
Quantity options	100 mg 10mM/1mL 10 mg 1 mg 25 mg 50 mg 5 mg
Item no.	HY-16111-1mg
Targets	Farnesyl Transferase
CASRN	195987-41-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	195987-41-8
Purity	99.58
Product Description	BMS-214662 is a potent and selective farnesyl transferase inhibitor with potent antitumor activity with an IC50 of 1.35 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	489.61
Clinical_Information	Phase 1
Manufacturers Research Area	Cancer
Solubility	DMSO : ≥ 100 mg/mL
Manufacturers Target	Farnesyl Transferase
Pathway	Metabolic Enzyme/Protease

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-16111-1mg-safety-datasheet.pdf